PL3027646T3 - Nowe wektory selekcyjne i sposoby selekcji eukariotycznych komórek gospodarza - Google Patents

Nowe wektory selekcyjne i sposoby selekcji eukariotycznych komórek gospodarza

Info

Publication number
PL3027646T3
PL3027646T3 PL14753158T PL14753158T PL3027646T3 PL 3027646 T3 PL3027646 T3 PL 3027646T3 PL 14753158 T PL14753158 T PL 14753158T PL 14753158 T PL14753158 T PL 14753158T PL 3027646 T3 PL3027646 T3 PL 3027646T3
Authority
PL
Poland
Prior art keywords
methods
host cells
eukaryotic host
selection vectors
novel selection
Prior art date
Application number
PL14753158T
Other languages
English (en)
Polish (pl)
Inventor
Yehuda G. Assaraf
Thomas Jostock
Hans-Peter Knopf
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PL3027646T3 publication Critical patent/PL3027646T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/65Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression using markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67General methods for enhancing the expression
    • C12N15/69Increasing the copy number of the vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00Nucleic acids vectors
    • C12N2800/40Systems of functionally co-operating vectors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
PL14753158T 2013-07-31 2014-07-29 Nowe wektory selekcyjne i sposoby selekcji eukariotycznych komórek gospodarza PL3027646T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361860439P 2013-07-31 2013-07-31
EP14753158.6A EP3027646B1 (en) 2013-07-31 2014-07-29 Novel selection vectors and methods of selecting eukaryotic host cells
PCT/IB2014/063517 WO2015015419A1 (en) 2013-07-31 2014-07-29 Novel selection vectors and methods of selecting eukaryotic host cells

Publications (1)

Publication Number Publication Date
PL3027646T3 true PL3027646T3 (pl) 2019-03-29

Family

ID=51383909

Family Applications (2)

Application Number Title Priority Date Filing Date
PL14753158T PL3027646T3 (pl) 2013-07-31 2014-07-29 Nowe wektory selekcyjne i sposoby selekcji eukariotycznych komórek gospodarza
PL18179678.0T PL3412684T3 (pl) 2013-07-31 2014-07-29 Nowe wektory selekcyjne i sposoby selekcji eukariotycznych komórek gospodarzy

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL18179678.0T PL3412684T3 (pl) 2013-07-31 2014-07-29 Nowe wektory selekcyjne i sposoby selekcji eukariotycznych komórek gospodarzy

Country Status (19)

Country Link
US (1) US11807855B2 (enExample)
EP (3) EP3412684B1 (enExample)
JP (1) JP6576924B2 (enExample)
KR (1) KR102288233B1 (enExample)
CN (2) CN105593239B (enExample)
AU (1) AU2014297966B2 (enExample)
BR (1) BR112016001182A2 (enExample)
CA (1) CA2918117C (enExample)
DK (2) DK3412684T3 (enExample)
ES (2) ES2920510T3 (enExample)
HU (1) HUE058885T2 (enExample)
IL (1) IL243352B (enExample)
LT (2) LT3027646T (enExample)
MX (1) MX369109B (enExample)
PL (2) PL3027646T3 (enExample)
PT (2) PT3412684T (enExample)
RU (1) RU2716977C2 (enExample)
SG (1) SG11201510625TA (enExample)
WO (1) WO2015015419A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9534226B2 (en) 2009-02-27 2017-01-03 Novartis Ag Expression vector system comprising two selection markers
PL3027646T3 (pl) 2013-07-31 2019-03-29 Novartis Ag Nowe wektory selekcyjne i sposoby selekcji eukariotycznych komórek gospodarza
EP4530350A3 (en) * 2015-10-09 2025-06-25 Genzyme Corporation Improved flare (flow cytometry attenuated reporter expression) technology for rapid bulk sorting
EP3521435A1 (en) 2018-02-06 2019-08-07 Bayer AG A high stringency selection system for protein expression in proline-auxotrophic cells
JP2021536263A (ja) * 2018-09-07 2021-12-27 メディミューン,エルエルシー 細胞選択の方法
PE20221416A1 (es) 2019-09-18 2022-09-20 Novartis Ag Proteinas de fusion nkg2d y sus usos
WO2022107090A1 (en) 2020-11-23 2022-05-27 Novartis Ag Expression technology for antibody constructs
WO2022229854A1 (en) 2021-04-29 2022-11-03 Novartis Ag Hypersialylating cells
US20250051758A1 (en) * 2021-12-21 2025-02-13 Absci Corporation FolA Selection Assay to Identify Strains with Increased Soluble Target Protein Expression

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4771036A (en) 1986-02-10 1988-09-13 Trustees Of Columbia University In The City Of New York Method and ophthalmic composition for the prevention and reversal of cataracts
JP2585532B2 (ja) 1986-05-10 1997-02-26 三井東圧化学株式会社 動物細胞の形質転換体及びそれを得る方法並びにその形質転換体を用いてt−PAを生産する方法
CA2096222C (en) 1990-11-13 1998-12-29 Stephen D. Lupton Bifunctional selectable fusion genes
EP0724639B1 (en) 1991-03-29 2001-01-31 Genentech, Inc. Methods for selection of recombinant host cells expressing high levels of a desired protein
AU6953394A (en) 1993-05-21 1994-12-20 Targeted Genetics Corporation Bifunctional selectable fusion genes based on the cytosine deaminase (cd) gene
US5439808A (en) 1993-07-23 1995-08-08 North American Vaccine, Inc. Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis
US5830698A (en) 1997-03-14 1998-11-03 Idec Pharmaceuticals Corporation Method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same
US6106825A (en) 1997-05-07 2000-08-22 University Of Florida Entomopoxvirus-vertebrate gene delivery vector and method
FR2784030B1 (fr) 1998-10-02 2002-12-20 Inst Nat Sante Rech Med Utilisation de bloqueurs des canaux calciques et/ou cgmp-dependants pour le traitement de pathologies de la retine
FR2823221B1 (fr) 2001-04-06 2004-04-02 Univ Pasteur Sequences associees a la degenerescence retinienne et applications
DE10256083A1 (de) 2002-11-29 2004-08-12 Boehringer Ingelheim Pharma Gmbh & Co. Kg Expressionsvektor, Verfahren zur Herstellung von heterologen Genprodukten und Selektionsverfahren für hochproduzierende rekombinante Zellen
US7384744B2 (en) 2002-11-29 2008-06-10 Boehringer Ingelheim Pharma Gmbh & Co., Kg Expression vector, methods for the production of heterologous gene products and for the selection of recombinant cells producing high levels of such products
ES2309508T3 (es) * 2003-03-11 2008-12-16 Laboratoires Serono Sa Vectores de expresion que comprenden el promotor de mcmv-ie2.
DK1716233T3 (da) 2004-01-30 2009-10-26 Maxygen Holdings Ltd Reguleret stopkodongennemlæsning
US20060275794A1 (en) 2005-03-07 2006-12-07 Invitrogen Corporation Collections of matched biological reagents and methods for identifying matched reagents
EP1987150B1 (en) 2006-02-21 2011-06-01 ChromaGenics B.V. Selection of host cells expressing protein at high levels
BRPI0712073B8 (pt) 2006-05-17 2021-05-25 Hoffmann La Roche ácido nucléico para produção de um polipeptídio ou proteína heteróloga
CN103805633B (zh) * 2007-12-21 2016-09-07 诺华股份有限公司 有机化合物
EP3075858B1 (en) 2007-12-21 2020-01-29 Novartis Ag Mammalian expression vector
ES2413379T3 (es) 2008-08-28 2013-07-16 Novartis Ag Presentación en la superficie celular de isoformas polipeptídicas mediante ultralectura de codón de terminación
WO2010029130A1 (en) 2008-09-10 2010-03-18 INSERM (Institut National de la Santé et de la Recherche Médicale) Neuronal viability factor and use thereof
CN102333875B (zh) 2009-02-27 2014-04-16 诺华股份有限公司 选择表达异源蛋白质的真核细胞的方法
US9534226B2 (en) 2009-02-27 2017-01-03 Novartis Ag Expression vector system comprising two selection markers
CN102030754B (zh) * 2009-09-28 2013-07-10 中国科学院微生物研究所 非病毒载体及其制备方法与应用
PL3027646T3 (pl) 2013-07-31 2019-03-29 Novartis Ag Nowe wektory selekcyjne i sposoby selekcji eukariotycznych komórek gospodarza

Also Published As

Publication number Publication date
CN105593239B (zh) 2020-10-16
LT3027646T (lt) 2018-09-25
US20160177318A1 (en) 2016-06-23
RU2716977C2 (ru) 2020-03-17
PL3412684T3 (pl) 2022-08-08
JP6576924B2 (ja) 2019-09-18
DK3027646T3 (en) 2018-09-24
EP4095153A1 (en) 2022-11-30
US11807855B2 (en) 2023-11-07
CN105593239A (zh) 2016-05-18
HUE058885T2 (hu) 2022-09-28
KR20160030524A (ko) 2016-03-18
CN112029791A (zh) 2020-12-04
ES2689136T3 (es) 2018-11-08
JP2016525366A (ja) 2016-08-25
PT3412684T (pt) 2022-06-27
RU2016106270A3 (enExample) 2018-04-27
CA2918117A1 (en) 2015-02-05
BR112016001182A2 (pt) 2017-08-29
EP3027646B1 (en) 2018-06-27
RU2016106270A (ru) 2017-08-31
LT3412684T (lt) 2022-07-11
IL243352B (en) 2018-06-28
AU2014297966A1 (en) 2016-01-28
EP3027646A1 (en) 2016-06-08
CA2918117C (en) 2023-01-24
KR102288233B1 (ko) 2021-08-10
WO2015015419A1 (en) 2015-02-05
ES2920510T3 (es) 2022-08-04
AU2014297966B2 (en) 2017-10-26
IL243352A0 (en) 2016-03-31
SG11201510625TA (en) 2016-02-26
EP3412684A1 (en) 2018-12-12
DK3412684T3 (da) 2022-07-04
MX2016001396A (es) 2016-05-05
PT3027646T (pt) 2018-10-16
EP3412684B1 (en) 2022-04-06
MX369109B (es) 2019-10-29

Similar Documents

Publication Publication Date Title
IL244791A0 (en) Methods for modifying a host cell
IL243352A0 (en) Novel selection vectors and methods for selection of eukaryotic host cells
EP3065875A4 (en) Bioprinter and methods of using same
EP2971040A4 (en) CELL CULTURE METHODS
EP2971014A4 (en) CELL CULTURE METHODS
IL240216B (en) Converted xanthines and methods of using them
EP3183703A4 (en) Temporal and spatial bounding of personal information
SG11201504771RA (en) Host cells and methods of use
HUE049806T2 (hu) Módosított gazdasejtek és alkalmazásaik
PL3083677T3 (pl) Nowe komórki eukariotyczne i sposoby rekombinowanej ekspresji produktu będącego przedmiotem zainteresowania
EP3027182A4 (en) Novel copper-cysteamine and methods of use
IL245272B (en) pif-transfected cells and methods of use
GB2517453B (en) Improved use of memory resources
GB201403107D0 (en) Permeability and transformation of cells
GB201306810D0 (en) Methods of cell separation
IL224391A (en) Mobile and insulated structure and method of manufacture
GB201312753D0 (en) Methods of making the Dipole Work greater than the Magnetisation Energy
GB201308639D0 (en) Biomarkers and uses of thereof
GB2515256B (en) Structural Beam and Kit of Connectors Therefor
GB201304546D0 (en) Methods of making the Dipole Work greater than the Magnetisation Energy
AU2013901572A0 (en) Thermo-Electrochemical Cell and Method of Use
GB201212007D0 (en) Methods of making the dipole work greater than the magnetisation energy